Evaluating the safety, tolerability, and efficacy of tulobuterol transdermal patch in patients with asthma or chronic obstructive pulmonary disease: A phase-IV clinical study
Tuloplast™ demonstrated excellent safety, tolerability, and efficacy in improving symptom control and lung function. Its once-daily application enhances adherence, making it a promising alternative for asthma and COPD management.
Authors
- Bhupesh Dewan (ORCID: https://orcid.org/0000-0002-0367-3142)
- Siddheshwar Shinde (ORCID: https://orcid.org/0000-0002-4790-9161)
- Rishima Ganiga
Publication Details
- Journal
- Annals of Thoracic Medicine
- Published
- 2025-08-29
- DOI
- https://doi.org/10.4103/atm.atm_98_25
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00